PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Hematology and Oncology, 2025Brookdale University Hospital and Medical Center, Brooklyn, NY, USA.\', \'Rehabilitation Sciences, 12337The University of Texas at El Paso, El Paso, TX, USA.\', \'Department of Internal Medicine, 2025Brookdale University Hospital and Medical Center, Brooklyn, NY, USA.\', \'Department of Internal Medicine, Paul L. Foster School of Medicine, 37316Texas Tech University, El Paso, TX, USA.\', \'Department of Nephrology, 2025Brookdale University Hospital and Medical Center, Brooklyn, NY, USA.\', \'New York Medical College, Hematology/Oncology research laboratory, 2025Brookdale University Hospital and Medical Center, Brooklyn, NY, USA.\', \'Tausig Cancer Center, Hematology/Oncology, Stem Cell Transplantation, 2569Cleveland Clinic, Cleveland, OH, USA.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1177/1073274820960457
?:hasPublicationType
?:journal
  • Cancer control : journal of the Moffitt Cancer Center
is ?:pmid of
?:pmid
?:pmid
  • 33043705
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • COVID-19 in Cancer Patients From New York City: A Comparative Single Center Retrospective Analysis.
?:type

Metadata

Anon_0  
expand all